1. A pharmaceutical agent for treating and / or preventing a disease caused by neovascularization of the choroid (neovascular maculopathy), which comprises at least one of the following peptides (a) to (c) as an active ingredient: (a) a peptide containing any amino acid sequence from SEQ ID NO: 1-12； (b) a peptide having one or more amino acid substitutions, deletions, additions and / or inserts in any amino acid sequence of SEQ ID NO: 1-6, in which the second amino acid with N-con tsa is leucine or methionine, and / or the C-terminal amino acid is valine or leucine, and wherein the peptide has cytotoxic T cell inducing activity； and (c) a peptide having one or more amino acid substitutions, deletions, additions and / or insertions into any amino acid sequence of SEQ ID NO: 7-12, in which the second amino acid from the N-terminus is phenylalanine, tyrosine, methionine or tryptophan and / or the C-terminal amino acid is phenylalanine, leucine, isoleucine, tryptophan or methionine, and where the peptide has cytotoxic T-cell inducing activity. 2. The pharmaceutical preparation according to claim 1, wherein the disease caused by neovascularization of the choroid (neovascular maculopathy) is selected from exudative age-related macular degeneration, myopic macular degeneration, angioid retinal bands, central exudative chorioretinopathy, various epithelialopathies associated with retinal pigmentation choroid, choroidemia and osteoma of the choroid. 3. Wacz1. Фармацевтическое средство для лечения и/или профилактики заболевания, вызванного неоваскуляризацией сосудистой оболочки глаза (неоваскулярная макулопатия), который включает, по меньшей мере, один из представленных ниже пептидов (a)-(c) в качестве активного ингредиента:(a) пептид, содержащий какую-либо аминокислотную последовательность из SEQ ID NO: 1-12；(b) пептид, имеющий одно или несколько аминокислотных замещений, делеций, добавлений и/или вставок в какую-либо аминокислотную последовательность из SEQ ID NO: 1-6, в к
